At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Biopsyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Feasibility of Establishing Patient-Derived Organoids for Rectal Cancer: A Biospecimen Collection Protocol
In Brief
A clinical study evaluating Biopsy for Rectum Cancer. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the feasibility of establishing patient-derived organoids from pre-treatment rectal adenocarcinoma biopsies.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRectum Cancer
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedMay 2020
Enrollment StartSep 2020
Primary CompletionAug 2022
TodayJul 2026
First PostedMay 1, 2020
Enrollment StartSep 18, 2020
Primary CompletionAug 17, 2022
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 6.2 years ago
Interventions
Biopsyother
Tissue biopsy